# A Study of NP-201 Acetate Injection in Healthy Adult Volunteers and in Patients With Mild-To-Moderate Active Ulcerative Colitis

> **NCT06681389** · PHASE1 · COMPLETED · sponsor: **NIBEC Co., Ltd.** · enrollment: 35 (actual)

## Conditions studied

- Healthy Adult Volunteers
- Active Ulcerative Colitis
- Active Ulcerative Colitis (UC)

## Interventions

- **DRUG:** NP-201 acetate injection (Part A)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06681389
- **Lead sponsor:** NIBEC Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-11-25
- **Primary completion:** 2025-07-18
- **Final completion:** 2025-09-04
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2026-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06681389

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06681389, "A Study of NP-201 Acetate Injection in Healthy Adult Volunteers and in Patients With Mild-To-Moderate Active Ulcerative Colitis". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT06681389. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*